New Paradigms in Lung Cancer Management 17 February 2022
Welcome & Introduction
Importance of molecular testing in treating Lung cancer
Newer Paradigms in the Treatment of Resected EGFRm Early Lung Cancer
Real world Evidence Osimertinib as SoC in the management of EGFRm NSCLC
Panel Discussion - Managing Early Stage Lung Cancer Patients